Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Embolic Protection Device(s) EPDs are used to capture and remove plaque debris that are dislodged during interventional procedures. GlobalData uses proprietary data and analytics to provide a comprehensive report on the peripheral embolic protection devices devices market, including market shares of different players within the UK. Buy the latest report here.

Smarter leaders trust GlobalData

In 2022, GlobalData’s Market Model methodology determined that the leading player in the peripheral embolic protection devices market in the UK was Medtronic followed by Boston Scientific, Abbott Laboratories, Cordis and Cardiovascular Systems.

Peripheral Embolic Protection Devices (EPDs) used in the lower extremity, carotid and renal arteries have been accounted for. Carotid Embolic Protection Devices and Lower Extremity Embolic Protection Devices are tracked under this segment. Angioplasty: Angioplasty is a minimally invasive interventional procedure that is used to surgically unblock an artery with excessive plaque build-up in order to restore normal blood flow. Embolic debris may become dislodged during angioplasty procedures. A carotid embolic protection device is used during removal of plaque by an interventional procedure on the carotid artery. A lower extremity embolic protection device is used during a peripheral angioplasty.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the peripheral embolic protection devices devices market within the UK was expected to be over $4m in 2022.

For the latest complete market share analysis of peripheral embolic protection devices device market in the UK, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.